2019
DOI: 10.1038/s41586-019-1856-1
|View full text |Cite
|
Sign up to set email alerts
|

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
145
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 197 publications
(155 citation statements)
references
References 40 publications
8
145
2
Order By: Relevance
“…This study also suggests that skin inflammation such as that induced by mut-CARD14 may promote BIR. Recent studies on patients with ulcerative colitis have revealed that human intestinal stem cells exposed to long-standing inflammation adapt to such inflammation by acquiring genetic and genomic alterations including LOH, associated with the downregulation of IL-17 signalling 11,12 . Furthermore, long-tract LOH is frequently seen in skin lesions of porokeratosis, a common autoinflammatory keratinisation disease 41 .…”
Section: Discussionmentioning
confidence: 99%
“…This study also suggests that skin inflammation such as that induced by mut-CARD14 may promote BIR. Recent studies on patients with ulcerative colitis have revealed that human intestinal stem cells exposed to long-standing inflammation adapt to such inflammation by acquiring genetic and genomic alterations including LOH, associated with the downregulation of IL-17 signalling 11,12 . Furthermore, long-tract LOH is frequently seen in skin lesions of porokeratosis, a common autoinflammatory keratinisation disease 41 .…”
Section: Discussionmentioning
confidence: 99%
“… 95 – 98 For example, despite the fact that NF-κB signaling pathway mutations are significantly enriched throughout the colon in patients with ulcerative colitis, these pathways are exceedingly rare in areas of the colon with dysplasia or colitis-associated cancer. 99 A recent study comparing epithelial organoids derived from 71 patients, 16 without colitis, 29 with colitis lacking dysplasia, and 26 from patients with colitis-associated cancer, showed mutations in the IL-17 signaling pathway that confer resistance to an IL-17A-induced apoptotic response. 100 Like novel chemotherapeutic testing for cancer, ulcerative colitis and normal colonic organoids can be treated with cytokines and bacterial components to recapitulate the colitis phenotype, and then treated with novel agents to assess suppression of the immune response and regeneration of normal crypts.…”
Section: Methodsmentioning
confidence: 99%
“…In accordance with this idea, Regnase-1 is involved in the remodeling of the epithelial tissue of patients who have ulcerative colitis (UC). An exome sequencing study showed that ZC3H12A mutation in Ser438, which is present within the DSGXXS motif, is highly enriched in the inflamed tissue of UC samples [146,147]. This mutant form of Regnase-1 is resistant to degradation induced by IL-17-mediated IKK activation and indicates that Regnase-1 suppresses chronic inflammation in the UC epithelium.…”
Section: The Role Of Posttranscriptional Regulation In Immune Homeostmentioning
confidence: 99%